What is Quibim?
Headquartered in Valencia, Spain, Quibim has established itself as a global authority in the field of whole-body medical imaging analysis. The company's flagship platform, Quibim Precision, functions as a comprehensive imaging ecosystem that empowers research teams and clinical practitioners to detect pathologies and monitor treatment efficacy across diverse body parts and imaging modalities. By leveraging an AI-first methodology, Quibim transforms raw imaging data into actionable quantitative biomarkers, effectively bridging the gap between diagnostic imaging and precision medicine. The company's market position is defined by its ability to integrate seamlessly into existing clinical workflows, providing high-fidelity insights that are essential for modern therapeutic development and patient care management.
How much funding has Quibim raised?
Quibim has raised a total of $50M across 1 funding round:
Series A
$50M
Series A (2025): $50M with participation from GoHub Ventures, Asabys Partners, and UI Investissement
Key Investors in Quibim
GoHub Ventures
GoHub Ventures is an early-stage venture capital fund that invests in founders developing B2B software and digital health solutions, providing long-term capital and hands-on support.
Asabys Partners
Asabys Partners is an investment firm based in Barcelona that focuses on fostering breakthrough innovation in healthcare and life sciences, aiming to improve patient outcomes through disruptive technology.
UI Investissement
UI Investissement supports the growth of small and medium businesses across France, acting as a strategic partner by providing smart money and operational guidance to help companies reach their full potential.
What's next for Quibim?
With this major strategic investment, Quibim is well-positioned to accelerate its international expansion and deepen its research and development capabilities. The company is expected to focus on enhancing its AI-driven diagnostic tools, potentially expanding its footprint in the pharmaceutical and clinical trial sectors where quantitative imaging is increasingly vital. By leveraging the expertise of its strategic backers, Quibim aims to solidify its leadership in the digital health landscape, focusing on operational efficiency and the continued refinement of its whole-body imaging solutions to meet the evolving demands of global healthcare providers.
See full Quibim company page
